Alexandre Chan
- Geriatrics and Gerontology top 0.5%
- Pharmaceutical Practices and Patient Outcomes 34
- Family Practice top 1%
- Oncology top 1%
- Cancer survivorship and care 62
- Cancer Treatment and Pharmacology 31
- Neutropenia and Cancer Infections 27
- Genetics top 1%
- Glioma Diagnosis and Treatment 34
- Dermatology top 0.5%
-
- Cancer-related cognitive impairment studies 78
-
- Childhood Cancer Survivors' Quality of Life 35
-
- Nausea and vomiting management 28
Alexandre Chan
300 papers receiving 6.3k citations
Peers
Comparison fields: 5 of 165
- Geriatrics and Gerontology 555
- Family Practice 196
- Oncology 2.4k
- Genetics 749
- Dermatology 517
Countries citing papers authored by Alexandre Chan
This map shows the geographic impact of Alexandre Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Chan more than expected).
Fields of papers citing papers by Alexandre Chan
This network shows the impact of papers produced by Alexandre Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Chan. The network helps show where Alexandre Chan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alexandre Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 4 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 3 | |
| 7 | 2024 | 5 | |
| 8 | 2024 | 4 | |
| 9 | 2024 | 8 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 19 | |
| 12 | 2022 | 19 | |
| 13 | 2020 | 17 | |
| 14 | 2020 | 11 | |
| 15 | 2019 | 12 | |
| 16 | 2019 | 9 | |
| 17 | 2018 | 74 | |
| 18 | Cancer nurses’ provision of survivorship care for patients with haematological malignancy | 2016 | 3 |
| 19 | 2015 | 2 | |
| 20 | 2012 | 7 |
About Alexandre Chan
Alexandre Chan is a scholar working on Geriatrics and Gerontology, Family Practice, Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 314 papers that have together received 6.5k indexed citations. Recurring topics across this work include Cancer-related cognitive impairment studies (78 papers), Cancer survivorship and care (62 papers), Childhood Cancer Survivors' Quality of Life (35 papers), Glioma Diagnosis and Treatment (34 papers), Pharmaceutical Practices and Patient Outcomes (34 papers), Cancer Treatment and Pharmacology (31 papers), Nausea and vomiting management (28 papers) and Neutropenia and Cancer Infections (27 papers). The work is most often cited by research in Geriatrics and Gerontology (555 citations), Family Practice (196 citations), Oncology (2.4k citations), Genetics (749 citations) and Dermatology (517 citations). Alexandre Chan has collaborated with scholars based in Singapore, United States and Australia. Frequent co-authors include Han Kiat Ho, Kevin Yi‐Lwern Yap, Yin Ting Cheung, Yi Ling Teo, Judith Lees, Terence Ng, Vivianne Shih, Raymond J. Chan, Maung Shwe and Raymond Ng. Their work appears in journals such as Supportive Care in Cancer, Journal of Clinical Oncology, Clinical Therapeutics, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Annals of Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.